Medicare Enrolled
Dr. Hector Preti, M.D.
Hematology & Oncology · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Preti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Preti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Preti
Dr. Hector Preti is a hematology & oncology specialist in Chicago, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Preti performed 1,262 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Preti received a total of $11,972 from 71 pharmaceutical and/or device companies across 433 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Preti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 46% volume in IL
$11,972 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,262
Medicare services
Top 46% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
564 | $0 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $95 | $218 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
129 | $11 | $61 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
83 | $19 | $179 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
81 | $23 | $161 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
70 | $107 | $640 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
34 | $49 | $124 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
27 | $57 | $118 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $93 | $312 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $89 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $53 | $208 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.0% high complexity
54.9% medium
33.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,972
Total received (2018-2024)
Avg $1,995/year across 6 years
Top 29% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
433
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,164
2023
$2,601
2022
$2,467
2020
$328
2019
$3,919
2018
$1,492
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$182
PFIZER INC.
$149
Daiichi Sankyo Inc.
$113
BeiGene USA, Inc.
$105
Merck Sharp & Dohme LLC
$104
Gilead Sciences, Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$62
Incyte Corporation
$53
TerSera Therapeutics LLC
$53
EMD Serono, Inc.
$49
Ipsen Biopharmaceuticals, Inc
$46
ARRAY BIOPHARMA INC
$39
AstraZeneca Pharmaceuticals LP
$29
JAZZ PHARMACEUTICALS INC.
$27
Tempus AI, Inc
$21
SERVIER PHARMACEUTICALS LLC
$20
E.R. Squibb & Sons, L.L.C.
$20
Celgene Corporation
$16
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
Exelixis Inc.
$3,489
PFIZER INC.
$961
Novartis Pharmaceuticals Corporation
$698
Amgen Inc.
$502
E.R. Squibb & Sons, L.L.C.
$417
AstraZeneca Pharmaceuticals LP
$394
Janssen Biotech, Inc.
$361
Merck Sharp & Dohme LLC
$343
Astellas Pharma US Inc
$236
Incyte Corporation
$229
Genentech USA, Inc.
$216
Gilead Sciences, Inc.
$212
Daiichi Sankyo Inc.
$197
Ipsen Biopharmaceuticals, Inc
$156
Seagen Inc.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$145
Bayer HealthCare Pharmaceuticals Inc.
$138
Celgene Corporation
$129
Kite Pharma, Inc.
$125
BeiGene USA, Inc.
$125
TerSera Therapeutics LLC
$123
EMD Serono, Inc.
$122
EISAI INC.
$120
Puma Biotechnology, Inc.
$119
Pharmacyclics LLC, An AbbVie Company
$119
GENZYME CORPORATION
$118
Eisai Inc.
$115
Adaptive Biotechnologies Corporation
$110
PharmaEssentia USA Corporation
$102
Coherus Biosciences Inc.
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Regeneron Healthcare Solutions, Inc.
$79
Rigel Pharmaceuticals, Inc.
$78
Bayer Healthcare Pharmaceuticals Inc.
$74
Merck Sharp & Dohme Corporation
$73
MorphoSys, US Inc.
$71
Spectrum Pharmaceuticals Inc.
$68
EUSA Pharma (US) LLC
$65
Octapharma USA, Inc.
$60
AVEO Pharmaceuticals, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$51
Dendreon Pharmaceuticals LLC
$49
Genmab U.S., Inc.
$48
Taiho Oncology, Inc.
$48
Epizyme, Inc.,
$47
Verastem, Inc.
$44
Mirati Therapeutics, Inc.
$43
ARRAY BIOPHARMA INC
$39
Foundation Medicine, Inc.
$37
Organon LLC
$35
GE HealthCare
$34
Deciphera Pharmaceuticals Inc.
$33
Jazz Pharmaceuticals Inc.
$31
Karyopharm Therapeutics Inc.
$27
MENARINI SILICON BIOSYSTEMS, INC.
$27
Inari Medical, Inc.
$24
Myriad Genetic Laboratories, Inc.
$24
Sirtex Medical Inc
$22
TAIHO ONCOLOGY, INC.
$22
AbbVie, Inc.
$21
CTI BioPharma Corp.
$21
Tempus AI, Inc
$21
SERVIER PHARMACEUTICALS LLC
$20
Apellis Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$18
ABBVIE INC.
$17
Lilly USA, LLC
$15
PUMA BIOTECHNOLOGY, INC.
$14
AMAG Pharmaceuticals, Inc.
$13
GlaxoSmithKline, LLC.
$13
Stemline Therapeutics Inc.
$12
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AVYCAZ · Alecensa · Aranesp · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · Cabometyx · Cellsearch · Copiktra · Creon · DARZALEX · ELIQUIS · ELREXFIO · ELZONRIS · ENHERTU · ERLEADA · Empaveli · Enhertu · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · Folotyn · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · ONTRUZANT · OPDIVO · Onivyde · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Phesgo · Pomalyst · PreciseTumor · Prolia · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · Rezlidhia · S · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
319
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Preti is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Preti experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Preti performed 564 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Preti receive payments from pharmaceutical companies?
Yes. Dr. Preti received a total of $11,972 from 71 companies across 433 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Preti's costs compare to other hematology & oncology specialists in Chicago?
Dr. Preti's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Preti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Chicago
Browse hematology & oncology specialists in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology